Clinical Trials
4 trialsNCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04848493 2025-06-13
VAX4FRAIL
Azienda USL Reggio Emilia - IRCCS
Completed
NCT04910295 2023-04-12
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
Seoul National University Hospital
Completed
NCT05009030 2022-07-29
VAC-CaP
Fundación GECP
Completed